Vivus (VVUS-1.2%) updates investors on its European strategy for Qsymia. The company says it has submitted a request to the EMA for scientific advice on using a "pre-specified interim analysis from ...
On September 17, 2020, the European Alliance for Access to Safe Medicines (EAASM) announced the availability of a report entitled Patient Safety and Nanomedicines: The need for a centralised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback